Table 4.

Association between patient, tumor and treatment related factors and EORTC QLQ-BN20.

	MEAN SCORES					P-value
Age at survey completion > 33	No	Yes
Visual Disorders	4	15				0.001*
Follow up greater than 21	No	Yes
Visual Disorders	3	15				< 0.001*
Gender	Male	Female
Headaches	21	11				0.008*
Presenting Symptom: motor weakness	No	Yes
Motor Dysfunction	12	25				0.006*
Tumor Recurrence	No	Yes
Weak Legs	5	15				0.038*
Extent resection	GTR	STR/bx
Bladder Control	5	23				<0.001*
Radiation Therapy	No	Yes
Visual Disorders	6	19				0.002*
Motor Dysfunction	12	28				0.006*
Weak Legs	5	22				0.001*
Bladder Control	4	30				<0.001*
Histology	Astrocytoma	Pilocytic Astrocytoma	Subependymal Giant Cell Astrocytoma
Seizures	5	3	21			0.009*
Post-Operative Treatment a	Observation	Radiation	Radiation + Chemotherapy
Visual Disorders	6	20	11			0.008*
Motor Dysfunction	13	26	30			0.037*
weak legs	5	17	44			0.001*
Bladder Control	4	24	67			<.0.001*
CNS location b	Brainstem	Cerebellum	Cortical	Deep Structures	Multiple
Motor Dysfunction	72	15	11	23	8	0.003*
Bladder Control	0	6	4	24	20	0.016*

Table represents only clinically and statistically significant factors affecting QOL parameters, full results in the appendix.

^aOnly 2 patients received radiation + chemotherapy

^bOnly 2 patients with brainstem tumors